Fujirebio Lumipulse G pTau 217 Plasma Calibrators recalled for inaccurate Alzheimer's test results
What this means
Fujirebio Diagnostics' Lumipulse G pTau 217 Plasma Calibrators (Model 81557) may produce inaccurate test results, causing patients to be incorrectly classified as having Alzheimer's-related amyloid pathology or flagged for unnecessary additional testing. The calibration issue leads to falsely elevated results that do not match established imaging and CSF tests.
- Stop using affected calibrator lots D5C6094U and D5C6125U immediately
- Contact Fujirebio Diagnostics for replacement calibrators or instructions
- Review recent patient test results from these lots with your laboratory director
- Notify patients who received results using these calibrators if recommended by your lab
The agency's original wording
Customers may experience inaccurate test results by observing a higher frequency of classification in the indeterminate and positive zone and/or low specificity when compared back to FDA-cleared CSF ratio/PET imaging, due to falsely elevated positive ratio or falsely elevated indeterminate ratio results causing an incorrect classification of a patient as having amyloid pathology associated with Alzheimer s disease (positive result) and/or requiring more clinical testing of that patient (indeterminate result).
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1303-2026Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering pet owners — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.